The drug that threw Martha Stewart into court over an insider trading scandal has just been approved by the FDA. Actually, this was the second attempt by drug maker Imclone to try for approval for the colon cancer therapy. It was rejected in 2001, and it was that tip that a negative review by the FDA was coming that led to the trading scandal.
Now, two years later, the drug has been cleared, so what does that mean to patients? The drug is called Erbitux, and it's intended for patients with advanced colon cancer. Studies show Erbitux can shrink tumors in colon cancer patients who are out of treatment options, but it is kind of ironic that the drug that got Martha Stewart in trouble has finally received the government okay, right in the middle of her high profile trial.